Insights

Innovative Oncology Focus Boundless Bio specializes in developing next-generation cancer therapeutics targeting extrachromosomal DNA, a cutting-edge area with high unmet medical needs. This focus opens opportunities to collaborate with pharmaceutical or biotech companies seeking novel oncology solutions or seeking to expand their pipeline with innovative treatments.

Growing Clinical Pipeline With ongoing development of multiple clinical-stage candidates and discovery-phase programs, Boundless Bio offers potential for strategic partnerships, licensing, or co-development agreements to accelerate product advancement and market entry.

Recent Funding and Public Status Having secured $100 million in funding and recently going public, Boundless Bio is positioned for rapid growth and increased investment. This presents opportunities for sales of research tools, CRO services, or partnership offerings aligned with their expansion needs.

Leadership and Industry Engagement The appointment of key executives like the Chief Medical Officer and participation in major healthcare conferences indicate a proactive approach to industry networking and clinical development. This creates avenues to engage with their leadership team for strategic collaborations and solution offerings.

Robust Technology Stack Utilizing advanced cloud and data management platforms such as Google Cloud Platform and Microsoft Azure, Boundless Bio shows an emphasis on modern tech infrastructure. Partnering to enhance their data analysis, cloud services, or laboratory automation capabilities could be a valuable sales opportunity.

Boundless Bio Tech Stack

Boundless Bio uses 8 technology products and services including Salesforce, MySQL, Microsoft Excel, and more. Explore Boundless Bio's tech stack below.

  • Salesforce
    Customer Relationship Management
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • Font Awesome
    Font Scripts
  • Google Cloud Platform
    Infrastructure As A Service
  • SAP Maintenance, Repair, and Overhaul
    Operations
  • Microsoft Azure
    Platform As A Service
  • C++
    Programming Languages

Media & News

Boundless Bio's Email Address Formats

Boundless Bio uses at least 1 format(s):
Boundless Bio Email FormatsExamplePercentage
FLast@boundlessbio.comJDoe@boundlessbio.com
73%
Last@boundlessbio.comDoe@boundlessbio.com
25%
FirstLast@boundlessbio.comJohnDoe@boundlessbio.com
1%
First.Last@boundlessbio.comJohn.Doe@boundlessbio.com
1%

Frequently Asked Questions

Where is Boundless Bio's headquarters located?

Minus sign iconPlus sign icon
Boundless Bio's main headquarters is located at 10955 Alexandria Way, Suite 100. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Boundless Bio's stock symbol?

Minus sign iconPlus sign icon
Boundless Bio is a publicly traded company; the company's stock symbol is BOLD.

What is Boundless Bio's official website and social media links?

Minus sign iconPlus sign icon
Boundless Bio's official website is boundlessbio.com and has social profiles on LinkedInCrunchbase.

What is Boundless Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Boundless Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Boundless Bio have currently?

Minus sign iconPlus sign icon
As of December 2025, Boundless Bio has approximately 55 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: R. C. D.Chief Financial Officer: J. R.Co-Founder: P. M.. Explore Boundless Bio's employee directory with LeadIQ.

What industry does Boundless Bio belong to?

Minus sign iconPlus sign icon
Boundless Bio operates in the Biotechnology Research industry.

What technology does Boundless Bio use?

Minus sign iconPlus sign icon
Boundless Bio's tech stack includes SalesforceMySQLMicrosoft ExcelFont AwesomeGoogle Cloud PlatformSAP Maintenance, Repair, and OverhaulMicrosoft AzureC++.

What is Boundless Bio's email format?

Minus sign iconPlus sign icon
Boundless Bio's email format typically follows the pattern of FLast@boundlessbio.com. Find more Boundless Bio email formats with LeadIQ.

How much funding has Boundless Bio raised to date?

Minus sign iconPlus sign icon
As of December 2025, Boundless Bio has raised $100M in funding. The last funding round occurred on May 16, 2023 for $100M.

Boundless Bio

Biotechnology ResearchCalifornia, United States51-200 Employees

Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.

When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes,  driving cancer cells to grow and allowing them to resist treatment.  At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive.

Our Culture:

At Boundless, you’ll experience what it means to be out in front of the wave. 
Our unprecedented science takes us to new shores, and our team navigates the best breaks. We’re leaders in our field, and we’re dedicated to the cause of understanding and treating intractable cancers.

Every employee at Boundless makes an unbridled impact on our capabilities and our culture. We’ll help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. 

We’re all in on this fight against cancer– collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. 

At Boundless, we’re all in. We are unbound by convention, bound to save lives. 


Career Inquiries
careers@boundlessbio.com

General Information Inquiries
info@boundlessbio.com

Section iconCompany Overview

Headquarters
10955 Alexandria Way, Suite 100
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BOLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $25M$50M

    Boundless Bio's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $100M

    Boundless Bio has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 16, 2023 in the amount of $100M.

  • $25M$50M

    Boundless Bio's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.